2
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months
Six months
This chart is shown by TradingView, which receives your IP address when it loads.
After each filing
9
Sep 17
Buy
Miller Joseph
Insider
1 week
−4.1%S&P +0.9%
1 month
+4.8%S&P +0.3%
3 months
Result in37 trading days
6 months
Result in100 trading days
Jun 17
Buy
Miller Joseph
Insider
1 week
+3.5%S&P −0.6%
1 month
+3.7%S&P +0.4%
3 months
+0.9%S&P +3.2%
6 months
Result in37 trading days
Mar 18
Buy
Miller Joseph
Insider
1 week
−3.1%S&P −0.4%
1 month
−3.0%S&P +7.7%
3 months
−4.9%S&P +12.3%
6 months
−4.1%S&P +15.9%
Mar 14
Sale
Donnley Deneen L
Insider
1 week
−5.5%S&P −1.8%
1 month
−4.5%S&P +4.9%
3 months
−5.9%S&P +13.1%
6 months
−7.3%S&P +13.8%
Mar 3
Sale
MULROW WILLIAM J
Insider
1 week
−0.9%S&P −0.5%
1 month
+1.4%S&P −3.4%
3 months
−6.9%S&P +12.0%
6 months
−2.6%S&P +12.6%
Show all 9
Dec 20, 2025
Buy
Miller Joseph
Insider
1 week
+1.3%S&P +0.3%
1 month
+5.4%S&P +0.6%
3 months
+12.5%S&P −3.8%
6 months
+14.2%S&P +7.8%
Dec 13, 2025
Sale
KILLIAN JOHN F
Insider
1 week
−0.8%S&P +0.9%
1 month
+3.2%S&P +2.0%
3 months
+15.1%S&P −2.6%
6 months
+9.5%S&P +9.5%
Sep 16, 2025
Buy
Miller Joseph
Insider
1 week
+3.1%S&P +0.8%
1 month
+7.0%S&P +1.1%
3 months
+4.9%S&P +3.4%
6 months
+20.8%S&P +0.8%
Jun 9, 2025
Sale
Rep. Rob Bresnahan
House
1 week
−1.0%S&P −0.9%
1 month
−1.8%S&P +3.7%
3 months
−4.4%S&P +8.5%
6 months
−4.9%S&P +13.9%
Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.
Filings for ED
52 held · newest 552 held · newest 2Loading the filings.
Aeon news and offers by email
New sources, new features and offers like our founding price. A few times a month at most. Stop any time.
Government contracts, last 12 months
Awards of $10M and up, from USAspending · context, not a signalNo contracts of $10M or more in the last 12 months.
Lobbying
Last four quartersNo lobbying reports on file.